Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Eclipsys Corporation by Allscripts-Misys Healthcare Solutions, Inc.

Possible breaches of fiduciary duty in connection with the proposed acquisition of Eclipsys Corporation (ECLP 18.80, -0.60, -3.09%) (referred to as "Eclipsys" or the "Company") by Allscripts-Misys Healthcare Solutions, Inc. (MDRX 16.90, -0.37, -2.14%)  (referred to as "Allscripts") in an all-stock transaction valued at approximately $1.3 billion.

The merger agreement has been approved by the Board of Directors of both Allscripts and Eclipsys. Under terms of the merger agreement, Eclipsys stockholders will receive 1.2 shares of Allscripts for each share of Eclipsys.The merger will be subject to stockholder approvals from both Allscripts and Eclipsys, and other closing conditions and regulatory approvals, including expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.

If you are a holder of Eclipsys stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

 

SOURCE: Bull & Lifshitz, LLP